Finance

Lists
Why is KBLB up 2,88%?
Dive Deeper
KBLB:OTCMKTS
Kraig Biocraft Laboratories Inc
USD 0,093
+2,88%
(+0,0026) 1D
9 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KBLB...
Open
USD 0,09
High
USD 0,09
Low
USD 0,08
Mkt. cap
104,19 m
Avg. vol.
1,30 m
Volume
302,25 k
52-wk high
USD 0,16
52-wk low
USD 0,06
EPS
-USD 0,00
Beta
1,59
Shares outstanding
1,12 mjd
No. of employees
41
Open
USD 0,09
High
USD 0,09
Low
USD 0,08
Mkt. cap
104,19 m
Avg. vol.
1,30 m
Volume
302,25 k
52-wk high
USD 0,16
52-wk low
USD 0,06
EPS
-USD 0,00
Beta
1,59
Shares outstanding
1,12 mjd
No. of employees
41
News stories
From web sources and news partners
Profile
Kraig Biocraft Laboratories, Inc. is an American biotechnology company headquartered in Ann Arbor, Michigan. It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences. Their most notable fiber is dragon silk which has been demonstrated to be tougher than many fibers used in bullet proof vests. Wikipedia
About Kraig Biocraft Laboratories Inc
CEO-
Employees41
Founded2006
HeadquartersAnn Arbor, Michigan, Verenigde State van Amerika
SectorCommodity chemical
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,24 k
68,75 k
66,70 k
64,37 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,42 m
653,92 k
758,80 k
639,06 k
Operating expense
1,43 m
722,67 k
825,50 k
703,43 k
Total operating expenses
1,43 m
722,67 k
825,50 k
703,43 k
Operating income
-1,43 m
-722,67 k
-825,50 k
-703,43 k
Other non operating income
-
-
-
-
EBT including unusual items
-1,51 m
-787,62 k
-942,72 k
-909,54 k
EBT excluding unusual items
-1,58 m
-860,85 k
-963,13 k
-835,52 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,51 m
-787,62 k
-942,72 k
-909,54 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,12 k
5,94 k
10,80 k
19,31 k
Interest expense
-144,26 k
-144,12 k
-148,43 k
-151,40 k
Net interest expenses
-143,14 k
-138,18 k
-137,63 k
-132,09 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,43 m
-715,07 k
-819,28 k
-696,33 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme